Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Microbot Medical Inc.

< Previous 1 2 3 Next >
Microbot Medical Closes $13 Million Registered Direct Offering
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Closes $8.6 Million Registered Direct Offering
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Shares Status Following Recent Geopolitical Events
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.